Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (4): 542-548    DOI: 10.12891/ceog4544.2019
Original Research Previous articles | Next articles
Effect of low molecular weight heparin on autotransplantation efficacy of ovarian tissues in rats
T. Toporcer1, T. Grendel2, I. Uhrinová3, S. F. Iannaccone4, A. Grendelová5, F. Sabol1, J. Belák6, S. Toporcerová7, *()
1Department of Heart Surgery, Medical faculty, Pavol Jozef Šafarik University and Eastern Slovak Institute for Cardiovascular Diseases Ltd., KoŠice, Slovakia
2Department of Anaesthesiology and Intensive Medicine, Medical faculty, Pavol Jozef Šafarik University and Eastern Slovak Institute for Cardiovascular Diseases Ltd., KoŠice, Slovakia
3Gyncare Centre of Assisted Reproduction, KoŠice, Slovakia
4Department of Forensic Medicine, Medical Faculty, Pavol Jozef Šafarik University, KoŠice, Slovakia
5Department of Gynaecology and Obstetrics, Medical Faculty, Pavol Jozef Šafarik University and 1st private Hospital KoŠice-Šaca Ltd., KoŠice, Slovakia
6Second Department of Surgery, Medical Faculty, Pavol Jozef Šafarik University and Louis Pasteur University Hospital, KoŠice, Slovakia
7Department of Gynaecology and Obstetrics, Medical Faculty, Pavol Jozef Šafarik University and Louis Pasteur University Hospital, KoŠice and Gyncare - Centre of Assisted Reproduction, KoŠice, Slovakia
Download:  PDF(1493KB)  ( 175 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Background: One of the most important problems of ovarian transplantation is the significant reduction in the number of primordial follicles during the short period after transplantation due to post-transplantation ischemia. The aim of the work was to evaluate the effect of enoxaparin application on follicular survival after cryopreserved and fresh ovary transplantation in rats. Materials and Methods: The study used female Sprague Dawley rats (n=56). The animals were ovariectomized and the healing of fresh and cryopreserved ovarian tissue was evaluated. Estrogen blood level, percentage of ovarian live tissue, and angiogenesis were evaluated 16 days after transplantation of fresh ovary and 7, 14, and 28 days after transplantation of cryopreserved ovarian tissue. The animals in the experimental groups were treated after transplantation by enoxaparin subcutaneously in doses of 200 IU/kg per day. Results: A statistically significant higher (p < 0.05) percentage of live tissue was recorded in the treated goup (14.5±6.5 vs. 20.6±5.7% in control vs. treated groups) 7 days after transplantation of cryopreserved ovarian tissue, and a significantly more intensive (p<0.005) neoangiogenesis was recorded in the treated group (12.7±1.9 capillaries in 250 μm2) in comparison with the control group (7.4±2.1 capillaries in 250 μm2) 28 days after transplantation of cryopreserved ovarian tissue. Conclusions: Administration of enoxaparin after transplantation of cryopreserved ovarian tissue may temporarily improve tissue survival. The use of enoxaparin does not adversely affect neoangiogenesis around the transplanted ovary. The positive effect of low molecular weight heparin application on neoangiogenesis was demonstrated four weeks after transplantation.

Key words:  Low molecular weight heparin      Ovary autotransplantation      Cryopreservation      Angiogenesis     
Published:  10 August 2019     
*Corresponding Author(s):  S. TOPORCEROVÁ     E-mail:  s.toporcerova@gmail.com

Cite this article: 

T. Toporcer, T. Grendel, I. Uhrinová, S. F. Iannaccone, A. Grendelová, F. Sabol, J. Belák, S. Toporcerová. Effect of low molecular weight heparin on autotransplantation efficacy of ovarian tissues in rats. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 542-548.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4544.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I4/542

[1] J.H. Check, D.L. Check, M.P. Dougherty, G. DiAntonio. Purposeful cryopreservation of sperm prior to intrauterine insemination to overcome the embryo implantation defect associated with sperm with a subnormal hypoosmotic swelling test[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 432-433.
[2] R. Csorba, P. Tsikouras, A. Bothou, S. Zervoudis, G. Iatrakis, X. Anthoulaki, D. Deuteraiou, A. Chalkidou, G. F. von Tempelhoff. Air travel during pregnancy: an update review and practical recommendation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 862-866.
[3] C. Hayashi, K. Matsumoto, K. Shinya, T. Nakajima, T. Nakao, A. Komatsu, F. Chishima, K. Kawana. The expression of angiotensin II receptors mRNA in granulosa-lutein cells in endometriosis patients who underwent ovarian surgery before in vitro fertilization[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 910-913.
[4] Yin Shao, Liguo Ma, Meiyi Chen, Yuxia Guo, Hongtao Xiao. The effect of VEGF and Ang-1 on cryopreserved human ovarian grafts in severe combined immunodeficient mice[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 377-382.
[5] Xiaomin Kanga, Tongfei Wanga, Shijin Xiaoa, Aimin Zhaoa. A successful pregnancy following 11 miscarriages in an unexplained recurrent pregnancy loss patient with thrombophilia: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 935-938.
[6] P. Bolehovska, D. Driak, M. Halaska, B. Asfaw, J. Novotny, I. Svandova. Disturbed angiogenesis in intrauterine growth restriction-compromised placentas at term[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 707-712.
[7] A.M. Malutan, R. Ciortea, C. Porumb, R.F. Mocan-Hognogi, D. Mihu. Vascular endothelial growth factor genetic polymorphisms at +405C/G and -460 C/T and the association with advanced stages of endometriosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 725-730.
[8] C. Sofoudis, I. Zervomanolakis, I. Galani, V. Grigoriou, D. Botsis, N. Vlahos. Assessment of follicle viability using fluorescence microscopy before and after ovarian thawing[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 305-309.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Prakash C. Deedwania. Management of Patients With Stable Angina and Type 2 Diabetes[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 105 -113 .
[5] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[6] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[7] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[8] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[9] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[10] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .